In five years since AlphaFold's debut, it has transformed basic biochemical research. But its long-term effect on drug discovery remains unclear.
On Tuesday, Google DeepMind and Isomorphic Labs announced a significant progress update on the next iteration of AlphaFold, the deep learning model that in 2020 cracked the problem of predicting a ...
Most of the activities that go on inside cells—the activities that keep us living, breathing, thinking animals—are handled by proteins. They allow cells to communicate with each other, run a cell’s ...
When John Jumper got the call earlier this month from the Royal Swedish Academy of Sciences that he was winning the Nobel Prize, he almost didn’t answer. The director of Google DeepMind, the tech ...
Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More A trio of scientists consisting of Demis Hassabis, co-founder and CEO of ...
The 2023 winners of the top prizes in biomedical research are emblematic of one of the driving forces of the field: to help see the unseen. Two technologies have been honored for their major ...
The team behind DeepMind’s protein structure prediction software AlphaFold announced Oct. 31 that it is expanding its model beyond proteins. Ligands, nucleic acids, and post-translational ...
Stability AI, the venture-backed startup behind the text-to-image AI system Stable Diffusion, is funding a wide-ranging effort to apply AI to the frontiers of biotech. Called OpenBioML, the endeavor's ...
Google DeepMind cofounder and CEO Demis Hassabis and John Jumper, a senior researcher at the company, shared the 2024 Nobel Prize for Chemistry for their work on AlphaFold, an AI model that predicts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback